07/03/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:23 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
4:32 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:39 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
4:46 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2025
3:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:55 PM | Kiniksa Pharmaceuticals International (Issuer)
Popovits Kimberly J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:59 PM | Kiniksa Pharmaceuticals International (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals International and its competitors with MarketBeat's FREE daily newsletter. |
06/05/2025
4:02 PM | Kiniksa Pharmaceuticals International (Issuer)
Malley Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
6:10 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
3:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
4:25 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:23 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
05/22/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:16 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:32 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
3:47 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:49 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:54 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:26 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:24 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
4:10 PM | Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
4:11 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
6:40 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
6:47 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:44 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
04/16/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:39 PM | Kiniksa Pharmaceuticals International (Filer)
| Form PRE 14A | |
04/09/2025
3:41 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
04/09/2025
3:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:43 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:44 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
5:57 PM | Kiniksa Pharmaceuticals International (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/03/2025
4:06 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:48 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:49 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:51 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:29 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:47 PM | Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
2:45 PM | Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:37 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:27 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:34 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:17 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:34 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
6:14 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:25 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:50 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
3:32 PM | HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Kiniksa Pharmaceuticals International (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:11 PM | Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
3:14 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G | |
10/17/2024
3:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:57 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
4:29 PM | BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13D/A | |
10/08/2024
4:08 PM | Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals International (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
3:40 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:14 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:02 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
09/04/2024
7:57 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:51 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:55 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:16 PM | Kiniksa Pharmaceuticals International (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
4:17 PM | Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:36 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
